Temporal profile of matrix metalloproteinases and their inhibitors in a human endothelial cell culture model of cerebral ischemia

Cerebrovascular Diseases

Volumn 35, Issue 6, 2013, Pages 514-520

  Reuter, Björn ^a   Rodemer, Claus ^a   Grudzenski, Saskia ^a   Couraud, Pierre Olivier ^c   Weksler, Babette ^d   Romero, Ignacio A ^e   Meairs, Stephen ^a   Bugert, Peter ^b   Hennerici, Michael G ^a   Fatar, Marc ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c INSTITUT COCHIN   (France)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e OPEN UNIVERSITY   (United Kingdom)

Author keywords

Blood brain barrier; Endothelial cells; Matrix metalloproteinases; Oxygen glucose deprivation; Stroke; Tissue inhibitors of metalloproteinases

Indexed keywords

GELATINASE A; GELATINASE B; GLUCOSE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; OXYGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN ISCHEMIA; BRAIN MICROVASCULAR ENDOTHELIAL CELL; CELL CULTURE; CELL GROWTH; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; CAPILLARY ENDOTHELIAL CELL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CELLS, CULTURED; CEREBRAL INFARCTION; ENDOTHELIAL CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84879480305     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000350731     Document Type: Article

References (38)

1. Gordon GR, Choi HB, Rungta RL, Ellis-Davies GC, MacVicar BA: Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature 2008; 456: 745-749.
2. Abbott NJ, Patabendige AA, Dolman DE, Yusof R, Begley DJ: Structure and function of the blood-brain barrier. Neurobiol Dis 2010; 37: 13-25.
3. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839. (Pubitemid 36542523)
4. Candelario-Jalil E, Yang Y, Rosenberg GA: Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in euroinflammation and cerebral ischemia. Neuroscience 2009; 158: 983-994.
5. Fatar M, Stroick M, Griebe M, Hennerici M: Matrix metalloproteinases in cerebrovascular diseases. Cerebrovasc Dis 2005; 20: 141-151. (Pubitemid 41254175)
6. del Zoppo GJ: The neurovascular unit, matrix proteases, and innate inflammation. Ann NY Acad Sci 2010; 1207: 46-49.
7. Cunningham LA, Wetzel M, Rosenberg GA: Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 2005; 50: 329-339. (Pubitemid 40780839)
8. Castellanos M, Serena J: Applicability of biomarkers in ischemic stroke. Cerebrovasc Dis 2007; 24(suppl 1):7-15. (Pubitemid 350035847)
9. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA: Matrix metalloproteinasemediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 2007; 27: 697-709. (Pubitemid 46474608)
10. Lischper M, Beuck S, Thanabalasundaram G, Pieper C, Galla HJ: Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions. Brain Res 2010; 1326: 114-127.
11. Liu W, Hendren J, Qin XJ, Shen J, Liu KJ: Normobaric hyperoxia attenuates early bloodbrain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. J Neurochem 2009; 108: 811-820.
12. Harkness KA, Adamson P, Sussman JD, Davies-Jones GA, Greenwood J, Woodroofe MN: Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain 2000; 123: 698-709. (Pubitemid 30162719)
13. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO: Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005; 19: 1872-1874. (Pubitemid 41598779)
14. Ben-Yosef Y, Lahat N, Shapiro S, Bitterman H, Miller A: Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ Res 2002; 90: 784-791. (Pubitemid 34633894)
15. Lee SR, Lo EH: Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation. J Cereb Blood Flow Metab 2004; 24: 720-727. (Pubitemid 38880217)
16. Ye H, Zheng Y, Ma W, Ke D, Jin X, Liu S, Wang D: Hypoxia down-regulates secretion of MMP-2, MMP-9 in porcine pulmonary arter endothelial and smooth muscle cells and the role of HIF-1. J Huazhong Univ Sci Technolog Med Sci 2005; 25: 382-384, 407.
17. Liu K, Chi L, Guo L, Liu X, Luo C, Zhang S, He G: The interactions between brain microvascular endothelial cells and mesenchymal stem cells under hypoxic conditions. Microvasc Res 2008; 75: 59-67. (Pubitemid 350266737)
18. Guo S, Stins M, Ning M, Lo EH: Amelioration of inflammation and cytotoxicity by dipyridamole in brain endothelial cells. Cerebrovasc Dis 2010; 30: 290-296.
19. Ben-Yosef Y, Miller A, Shapiro S, Lahat N: Hypoxia of endothelial cells leads to mmp-2-dependent survival and death. Am J Physiol Cell Physiol 2005; 289:C1321-C1331. (Pubitemid 41456849)
20. Chen SC, Liu YC, Shyu KG, Wang DL: Acute hypoxia to endothelial cells induces activating transcription factor 3 (ATF3) expression that is mediated via nitric oxide. Atherosclerosis 2008; 201: 281-288.
21. Cowan KM, Easton AS: Neutrophils block permeability increases induced by oxygen glucose deprivation in a culture model of the human blood-brain barrier. Brain Research 2010; 1332: 20-31.
22. Slevin M, Krupinski J, Rovira N, Turu M, Luque A, Baldellou M, Sanfeliu C, de Vera N, Badimon L: Identification of pro-angiogenic markers in blood vessels from stroked-affected brain tissue using laser-capture microdissection. BMC Genom 2009; 10: 113.
23. Ramos-Fernandez M, Bellolio MF, Stead LG: Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review. J Stroke Cerebrovasc Dis 2011; 20: 47-54.
24. Rosenberg GA, Estrada EY, Dencoff JE: Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998; 29: 2189-2195. (Pubitemid 28443538)
25. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH: Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 2000; 20: 1681-1689.
26. Fujimura M, Gasche Y, Morita-Fujimura Y, Massengale J, Kawase M, Chan PH: Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 1999; 842: 92-100. (Pubitemid 29447856)
27. Park KP, Rosell A, Foerch C, Xing C, Kim WJ, Lee S, Opdenakker G, Furie KL, Lo EH: Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats. Stroke 2009; 40: 2836-2842.
28. Harris AK, Ergul A, Kozak A, Machado LS, Johnson MH, Fagan SC: Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke. BMC Neurosci 2005; 6: 49.
29. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC: Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998; 29: 1020-1030. (Pubitemid 28228167)
30. Rosell A, Ortega-Aznar A, Alvarez-Sabin J, Fernandez-Cadenas I, Ribo M, Molina CA, Lo EH, Montaner J: Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 006; 37: 1399-1406.
31. Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS, Shapiro SD, Chan PH, Park TS: Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol 2005; 289:H558-H568. (Pubitemid 41129369)
32. Justicia C, Panes J, Sole S, Cervera A, Deulofeu R, Chamorro A, Planas AM: Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab 2003; 23: 1430-1440. (Pubitemid 38018261)
33. Zozulya A, Weidenfeller C, Galla HJ: Pericyte-endothelial cell interaction increases MMP-9 secretion at the blood-brain barrier in vitro. Brain Res 2008; 1189: 1-11. (Pubitemid 351842544)
34. Takata F, Dohgu S, Matsumoto J, Takahashi H, Machida T, Wakigawa T, Harada E, Miyaji H, Koga M, Nishioku T, Yamauchi A, Kataoka Y: Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-alpha, releasing matrix metalloproteinase-9 and migrating in vitro. J Neuroinflammation 2011; 8: 106.
35. Tejima E, Zhao BQ, Tsuji K, Rosell A, van Leyen K, Gonzalez RG, Montaner J, Wang X, Lo EH: Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage. J Cereb Blood Flow Metab 2007; 27: 460-468.
36. Ottino P, Finley J, Rojo E, Ottlecz A, Lambrou GN, Bazan HE, Bazan NG: Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroidretinal endothelial cells: involvement of cytosolic phospholipase a2 activity. Mol Vis 2004; 10: 341-350. (Pubitemid 41358265)
37. Roland I, Minet E, Ernest I, Pascal T, Michel G, Remacle J, Michiels C: Identification of hypoxia-responsive messengers expressed in human microvascular endothelial cells using differential display RT-PCR. Eur J Biochem/ FEBS 2000; 267: 3567-3574. (Pubitemid 30423017)
38. Lahat N, Bitterman H, Engelmayer-Goren M, Rosenzweig D, Weiss-Cerem L, Rahat MA: Reduced TIMP-2 in hypoxia enhances angiogenesis. Am J Physiol Cell Physiol 2011; 300:C557-C566.